Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
16-Jan-2018Corrigendum: Inhibitor selectivity for cyclin-dependent kinase 7: a structural, thermodynamic, and modelling studyHazel, P; Kroll, SHB; Bondke, A; Barbazanges, M; Patel, H, et al
20-Aug-2016ICEC0942, an orally bioavailable selective inhibitor of CDK7 for breast cancerAli, S; Patel, H; Periyasamy, M; Bondke, A; Slafer, BW, et al
15-Mar-2018ICEC0942, an orally bioavailable selective inhibitor of CDK7 for cancer treatmentAli, S; Patel, H; Periyasamy, M; Sava, G; Bondke, A, et al
28-Aug-2015Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancerLin, M-L; Patel, H; Remenyi, J; Banerji, CRS; Lai, C-F, et al
1-Aug-2016Cytidine deamination activity of APOBEC3B regulates estrogen receptor function in breast cancerPeriyasamy, M; Nguyen, VTM; Patel, H; Lai, C-F; Nevedomskaya, E, et al
26-Sep-2013Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistanceKaliszczak, M; Patel, H; Kroll, SHB; Carroll, L; Smith, G, et al
14-Jun-2016CDK7, cyclin H and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor- positive breast cancerPatel, H; Abduljabbar, R; Lai, CF; Periyasamy, M; Harrod, A, et al
24-Sep-2015APOBEC3B mediated cytidine deamination is required for estrogen receptor action in breast cancerAli, S; Periyasamy, M; Patel, H; Lai, C-F; Nguyen, VTM, et al
14-Jun-2016Expression of CDK7, cyclin H and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor positive breast cancerPatel, H; Abduljabbar, R; Chun-Fui, L; Periyasamy, M; Harrod, A, et al